Copay Accumulator-Type Programs Proposed For ACA Exchange Plans
Annual payment rule for individual and group plans governed by Affordable Care Act proposes excluding drug manufacturer-sponsored copay assistance from out-of-pocket caps and seeks comments on use of reference pricing.
You may also be interested in...
Payer efforts to undercut copay assistance are getting manufacturers’ attention. PhRMA launches ad campaign warning patients that 'middlemen' are 'trying to keep you from reaching your deductible.'
More payers are implementing programs that block manufacturer copay coupons for specialty drugs from being applied to deductibles and out-of-pocket maximums, exposing members to higher drug costs.
340B Hospitals Charging Private Insurers Nearly Four Times Acquisition Costs On Cancer Drugs – Study
New report makes a case for further scrutiny of the 340B program's contributions to high drug costs, although manufacturers remain the main target of legislative and regulatory reform proposals.